Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation.

[1]  Kenji Suzuki,et al.  Induced microsomal PGE synthase-1 is involved in cyclooxygenase-2-dependent PGE2 production in gastric fibroblasts. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[2]  E. Schwarz,et al.  PGE2 inhibits chondrocyte differentiation through PKA and PKC signaling. , 2004, Experimental cell research.

[3]  R. Breyer,et al.  Generation of a conditional allele of the mouse prostaglandin EP4 receptor , 2004, Genesis.

[4]  F. Berenbaum,et al.  Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p38 signaling pathways. , 2004, Arthritis and rheumatism.

[5]  Y. Kuroda,et al.  Prostaglandin E2 receptors EP2 and EP4 are up‐regulated in peritoneal macrophages and joints of pristane‐treated mice and modulate TNF‐α and IL‐6 production , 2004, Journal of leukocyte biology.

[6]  E. Schwarz,et al.  Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. , 2004, Bone.

[7]  J. Hoyland,et al.  Apoptosis of terminal hypertrophic chondrocytes in an in vitro model of endochondral ossification , 2003, The Journal of pathology.

[8]  E. Chien,et al.  Expression and regulation of the rat prostaglandin E2 receptor type 4 (EP4) in pregnant cervical tissue. , 2003, American journal of obstetrics and gynecology.

[9]  S. Narumiya,et al.  Prostaglandin E2–EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells , 2003, Nature Medicine.

[10]  J. Morrow,et al.  Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. , 2003, The Journal of clinical investigation.

[11]  L. Audoly,et al.  The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. , 2002, The Journal of clinical investigation.

[12]  G. Boland,et al.  Wnt-3A Enhances Bone Morphogenetic Protein-2-mediated Chondrogenesis of Murine C3H10T1/2 Mesenchymal Cells* , 2002, The Journal of Biological Chemistry.

[13]  S. Narumiya,et al.  Function of prostanoid receptors: studies on knockout mice. , 2002, Prostaglandins & other lipid mediators.

[14]  T. Suda,et al.  Mesenchymal Stem Cells in Perichondrium Express Activated Leukocyte Cell Adhesion Molecule and Participate in Bone Marrow Formation , 2002, The Journal of experimental medicine.

[15]  A. M. Simon,et al.  Cyclo‐Oxygenase 2 Function Is Essential for Bone Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  E. Schwarz,et al.  Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. , 2002, The Journal of clinical investigation.

[17]  R. Breyer,et al.  Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. , 2002, Bone.

[18]  S. Narumiya,et al.  Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Phipps,et al.  Prostaglandins as modulators of immunity. , 2002, Trends in immunology.

[20]  M. Zasloff,et al.  Antiangiogenic Treatment Delays Chondrocyte Maturation and Bone Formation During Limb Skeletogenesis , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  B. Koller,et al.  Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. , 2001, The Journal of clinical investigation.

[22]  S. Narumiya,et al.  Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice , 2001, Nature Medicine.

[23]  B. Boyan,et al.  Characterization of PGE2 receptors (EP) and their role as mediators of 1α,25-(OH)2D3 effects on growth zone chondrocytes , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[24]  V. Goldberg,et al.  BMP‐2 induction and TGF‐β1 modulation of rat periosteal cell chondrogenesis , 2001 .

[25]  A. Ristimäki,et al.  Regulated expression of prostaglandin E(2) receptors EP2 and EP4 in human ovarian granulosa-luteal cells. , 2001, The Journal of clinical endocrinology and metabolism.

[26]  Soken Tsuchiya,et al.  The Expression of Prostaglandin E Receptors EP2 and EP4 and Their Different Regulation by Lipopolysaccharide in C3H/HeN Peritoneal Macrophages1 , 2001, The Journal of Immunology.

[27]  D. Macdonald,et al.  Nonunion of the femoral diaphysis , 2000 .

[28]  F. Silverstein,et al.  Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor , 2000, American Journal of Gastroenterology.

[29]  P. Billings,et al.  MMP‐13 is induced during chondrocyte hypertrophy , 2000, Journal of cellular biochemistry.

[30]  B. Galer,et al.  A Drug Use Evaluation of Selected Opioid and Nonopioid Analgesics in the Nursing Facility Setting , 2000, Journal of the American Geriatrics Society.

[31]  Y. Kitamura,et al.  Cbfa1 Is a Positive Regulatory Factor in Chondrocyte Maturation* , 2000, The Journal of Biological Chemistry.

[32]  B. Boyan,et al.  24R,25‐(OH)2D3 mediates its membrane receptor‐dependent effects on protein kinase C and alkaline phosphatase via phospholipase A2 and cyclooxygenase‐1 but not cyclooxygenase‐2 in growth plate chondrocytes , 2000, Journal of cellular physiology.

[33]  M. M. Dozier,et al.  Inhibition of prostaglandin synthesis reduces cyclic AMP levels and inhibits chondrogenesis in cultured chick limb mesenchyme. , 2000, Methods in cell science : an official journal of the Society for In Vitro Biology.

[34]  M. García-Ramírez,et al.  Vascular Endothelial Growth Factor Is Expressed in Human Fetal Growth Cartilage , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  Vicki Rosen,et al.  Regulation of Skeletal Progenitor Differentiation by the Bmp and Retinoid Signaling Pathways , 2000, The Journal of cell biology.

[36]  D. Dean,et al.  Characterization of prostaglandin E2 receptors and their role in 24,25‐(OH)2D3‐mediated effects on resting zone chondrocytes , 2000, Journal of cellular physiology.

[37]  L. Titus,et al.  Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusion. , 1999, Spine.

[38]  Theodore Miclau,et al.  Does adult fracture repair recapitulate embryonic skeletal formation? , 1999, Mechanisms of Development.

[39]  J. Compston,et al.  Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage , 1999, Journal of anatomy.

[40]  B. Boyan,et al.  Prostaglandins mediate the effects of 1,25-(OH)2D3 and 24,25-(OH)2D3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner. , 1999, Bone.

[41]  Richard R. Behringer,et al.  Sox9 is required for cartilage formation , 1999, Nature Genetics.

[42]  A. Rapoff,et al.  Posterolateral fusion for isthmic spondylolisthesis in adults: analysis of fusion rate and clinical results. , 1998, Journal of spinal disorders.

[43]  Susan W. Volk,et al.  A BMP Responsive Transcriptional Region in the Chicken Type X Collagen Gene , 1998 .

[44]  P. Lipsky,et al.  Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. , 1998, Arthritis and rheumatism.

[45]  Gwo‐Jaw Wang,et al.  Effects of Ketorolac on Bone Repair: A Radiographic Study in Modeled Demineralized Bone Matrix Grafted Rabbits , 1998, Pharmacology.

[46]  John R. Johnson,et al.  The Effect of Postoperative Nonsteroidal Anti‐inflammatory Drug Administration on Spinal Fusion , 1998, Spine.

[47]  D. Zaleske,et al.  Response of physeal cartilage to low-level compression and tension in organ culture. , 1998, Journal of pediatric orthopedics.

[48]  Giuseppe M Peretti,et al.  Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair , 1998, Mechanisms of Development.

[49]  B. Koller,et al.  The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth , 1997, Nature.

[50]  N. Lane,et al.  Pain management in osteoarthritis: the role of COX-2 inhibitors. , 1997, The Journal of rheumatology. Supplement.

[51]  L. Crofford,et al.  COX-1 and COX-2 tissue expression: implications and predictions. , 1997, The Journal of rheumatology. Supplement.

[52]  Patrick P.L. Tam,et al.  SOX9 directly regulates the type-ll collagen gene , 1997, Nature Genetics.

[53]  P N Goodfellow,et al.  SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene , 1997, Molecular and cellular biology.

[54]  J. Puzas,et al.  Differential regulation of type‐II and type‐X collagen synthesis by parathyroid hormone‐related protein in chick growth‐plate chondrocytes , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[55]  S. Reuben,et al.  Ketorolac as an Adjunct to Patient-Controlled Morphine in Postoperative Spine Surgery Patients , 1996, Regional Anesthesia & Pain Medicine.

[56]  R. Phipps,et al.  Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  William A. Ante,et al.  The Effects of Nonsteroidal Anti‐inflammatory Drugs on Posterior Spinal Fusions in the Rat , 1996, Spine.

[58]  A. Egbert,et al.  Postoperative pain management in the frail elderly. , 1996, Clinics in geriatric medicine.

[59]  C. Patry,et al.  Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture , 1996, British journal of pharmacology.

[60]  L. Gerstenfeld,et al.  Expression of bone‐specific genes by hypertrophic chondrocytes: Implications of the complex functions of the hypertrophic chondrocyte during endochondral bone development , 1996, Journal of cellular biochemistry.

[61]  K Banovac,et al.  Effect of Nonsteroidal Antiinflammatory Drugs on Fracture Healing: A Laboratory Study in Rats , 1995, Journal of orthopaedic trauma.

[62]  F. Blanco,et al.  Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. , 1995, Journal of immunology.

[63]  M. Fredericson,et al.  Tibial Stress Reaction in Runners , 1995, The American journal of sports medicine.

[64]  B. Hirschowitz,et al.  Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. , 1994, The Gastroenterologist.

[65]  K. Seibert,et al.  Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[66]  B. Bak,et al.  Effect of local prostaglandin E2 on fracture callus in rabbits. , 1993, Acta orthopaedica Scandinavica.

[67]  M. Glimcher,et al.  High‐resolution immunolocalization of osteopontin and osteocalcin in bone and cartilage during endochondral ossification in the chicken tibia , 1992, The Anatomical record.

[68]  J. Puzas,et al.  Influence of prostaglandins on DNA and matrix synthesis in growth plate chondrocytes , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[69]  A. A. Capehart,et al.  Comparative effects of cytosine arabinoside and a prostaglandin E2 antagonist, AH6809, on chondrogenesis in serum-free cultures of chick limb mesenchyme. , 1991, Experimental cell research.

[70]  A. A. Capehart,et al.  Effects of a putative prostaglandlin E2 antagonist, AH6809, on chondrogenesis in serum‐free cultures of chick limb mesenchyme , 1991, Journal of cellular physiology.

[71]  M. M. Dozier,et al.  Responsiveness of adenylate cyclase to PGE2 and forskolin in isolated cells from micromass cultures of chick limb mesenchyme during chondrogenesis. , 1990, Prostaglandins.

[72]  M. M. Dozier,et al.  Inhibition of chondrogenesis by retinoic acid in limb mesenchymal cells in vitro: effects on PGE2 and cyclic AMP concentrations. , 1988, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[73]  L. Sawyer,et al.  Chondrogenesis in chick limb mesenchyme in vitro derived from distal limb bud tips: Changes in cyclic AMP and in prostaglandin responsiveness , 1988, Journal of cellular physiology.

[74]  R. Norrdin,et al.  Systemic effects of prostaglandin E2 on vertebral trabecular remodeling in beagles used in a healing study , 1988, Calcified Tissue International.

[75]  W. Jee,et al.  Effect of 16, 16‐dimethyl prostaglandin E2 methyl ester on weanling rat skeleton: Daily and systemic administration , 1986, The Anatomical record.

[76]  H. Bèzes,et al.  Comparison of the efficacy and tolerance of isoxicam and piroxicam following surgery for skiing accidents. , 1986, British journal of clinical pharmacology.

[77]  R. Kosher,et al.  The effect of prostaglandins on the cyclic AMP content of limb mesenchymal cells. , 1985, Cell differentiation.

[78]  L. Sawyer,et al.  Chondrogenesis of chick limb mesenchyme in vitro. Effects of prostaglandins on cyclic AMP. , 1984, Experimental cell research.

[79]  W. C. Ho,et al.  Arachidonate metabolism during chondrogenesisin vitro , 1984, Calcified Tissue International.

[80]  R. Kosher,et al.  The effect of prostaglandins on in vitro limb cartilage differentiation. , 1983, Experimental cell research.

[81]  R. Majeska,et al.  Biosynthesis and metabolism of prostaglandins in chick epiphyseal cartilage. , 1977, Prostaglandins.

[82]  R. Breyer,et al.  Targeted gene disruption of the prostaglandin E2 EP2 receptor. , 2002, Advances in experimental medicine and biology.

[83]  R. Cancedda,et al.  Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. , 2000, Journal of cell science.

[84]  R. Cancedda,et al.  Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113(Pt 1):59-69 , 2000 .

[85]  T. Takano,et al.  Cyclooxygenases-1 and 2 couple to cytosolic but not group IIA phospholipase A2 in COS-1 cells. , 2000, Prostaglandins & other lipid mediators.

[86]  M. Weinreb,et al.  Differential effects of systemic prostaglandin E2 on bone mass in rat long bones and calvariae. , 1998, The Journal of endocrinology.

[87]  M. V. van Leeuwen,et al.  Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. , 1997, The Journal of rheumatology.

[88]  S. Fuchs,et al.  Evaluation of ketorolac in children with forearm fractures. , 1997, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[89]  K. Giercksky,et al.  Epidemiology of NSAID-related gastrointestinal side effects. , 1989, Scandinavian journal of gastroenterology. Supplement.

[90]  D. Woodbury,et al.  The effects of prostaglandin E2 in rapidly growing rats: depressed longitudinal and radial growth and increased metaphyseal hard tissue mass. , 1985, Bone.